• About us
• Contact

Advertisement

Organisation › Details

Genomics England Ltd.

Genomics England (www.genomicsengland.co.uk) was incorporated on 17 April 2013 as a company to take forward the Prime Minister's 100,000 Genome Project. The Project will introduce high-tech DNA mapping for rare diseases patients and those with cancer or infectious diseases and link that new data to the patient's medical records. This will give doctors a new advanced understanding of a patient's genetic make-up, condition, and treatment needs, ensuring they have access to the right drugs and personalised care far quicker than ever before. Genomics England Limited is owned by the UK Department of Health. *

 

	Start	2013-04-17 established
	Group	United Kingdom (GB) (govt)
	Industry	genome sequencing
	Industry 2	genomics
	Person	Symonds, Jonathan (Novartis 200909–201304 STEPPED DOWN 4/13 before Goldman Sachs + AstraZeneca CFO)
	Person 2	Caulfield, Mark (Genomics England 201901– interim Chief Executive)
	Region	United Kingdom (town unspecified)
	Country	United Kingdom (GB)
	Street	Charterhouse Square Dawson Hall
	City	EC1M 6BQ London
	Tel	+44-207-882-6392
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-10-25

Advertisement

More documents for United Kingdom (GB) (govt)

• [1] Earlybird VC Management GmbH & Co KG. (2/14/24). "Press Release: Earlybird Health Closes Fresh Fund of EUR 173m". Berlin & Cologne....
• [2] Cresset Biomolecular Discovery Ltd.. (10/18/23). "Press Release: Cresset Targets International Growth with Innovate UK Scaleup Programme". Cambridge....
• [3] Exscientia plc. (10/17/23). "Press Release: Parker Moss to Join Exscientia as EVP, Corporate Development". Oxford....
• [4] Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise"....
• [5] Moderna, Inc.. (6/21/22). "Press Release: Moderna Announces Plan to Bring mRNA Innovation to the United Kingdom". Cambridge, MA....
• [6] Sano Genetics Ltd.. (1/25/21). "Press Release: Sano Genetics Accelerates Research into Long Covid after Raising £2.5M ($3.2M) in Seed funding"....
• [7] BioNTech SE. (7/20/20). "Press Release: Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz....
• [8] Epidarex Capital. (6/22/20). "Press Release: Epidarex Capital Closes New £102 Million UK Venture Fund to Build Successful Life Science Companies". Edinburgh....
• [9] Bicycle Therapeutics plc. (4/23/20). "Press Release: Bicycle Therapeutics Appoints Zafar Qadir as General Counsel". Cambridge & Boston, MA....
• [10] UK Biobank. (9/11/19). "Press Release: UK Biobank Leads the Way in Genetics Research to Tackle Chronic Diseases"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.